Dorman Products, Inc. (NASDAQ:DORM – Get Free Report) Director Steven L. Berman sold 215 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $117.01, for a total value of $25,157.15. Following the completion of the sale, the director now owns 881,298 shares in the company, valued at $103,120,678.98. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
Dorman Products Price Performance
Dorman Products stock opened at $115.30 on Wednesday. The stock has a market capitalization of $3.52 billion, a price-to-earnings ratio of 23.20 and a beta of 0.83. Dorman Products, Inc. has a 52-week low of $60.01 and a 52-week high of $119.28. The stock’s 50 day moving average price is $107.61 and its two-hundred day moving average price is $97.34. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.19 and a current ratio of 2.40.
Dorman Products (NASDAQ:DORM – Get Free Report) last posted its quarterly earnings results on Thursday, August 1st. The auto parts company reported $1.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.19 by $0.48. The firm had revenue of $502.95 million for the quarter, compared to analysts’ expectations of $497.46 million. Dorman Products had a return on equity of 15.97% and a net margin of 8.75%. The company’s revenue for the quarter was up 4.7% compared to the same quarter last year. During the same period in the prior year, the business earned $1.01 EPS. On average, equities analysts predict that Dorman Products, Inc. will post 6.15 earnings per share for the current year.
Hedge Funds Weigh In On Dorman Products
Analysts Set New Price Targets
Several analysts recently commented on the company. Roth Mkm reiterated a “buy” rating and issued a $116.00 target price on shares of Dorman Products in a report on Friday, June 14th. CJS Securities assumed coverage on Dorman Products in a report on Friday, September 13th. They issued an “outperform” rating and a $134.00 target price on the stock. Four analysts have rated the stock with a buy rating, According to MarketBeat, Dorman Products has an average rating of “Buy” and an average target price of $113.33.
Check Out Our Latest Report on DORM
Dorman Products Company Profile
Dorman Products, Inc supplies replacement and upgrade parts for passenger cars, light trucks, medium- and heavy-duty trucks, utility terrain vehicles, and all-terrain vehicles in the motor vehicle aftermarket industry in the United States and internationally. It offers engine products, including intake and exhaust manifolds, fans, thermostat housings, and throttle bodies; undercar products comprising fluid lines, fluid reservoirs, connectors, 4-wheel drive components and axles, drain plugs, other engine, and transmission and axle components; steering and suspension products consist of control arms, ball joints, tie-rod ends, brake hardware and hydraulics, wheel and axle hardware, suspension arms, knuckles, links, bushings, and leaf springs, as well as other suspension, steering, and brake components; body products, such as door handles and hinges, window lift motors, window regulators, switches and handles, wiper components, lighting, electrical, and other interior and exterior vehicle body components, including windshields for UTVs; electronics products comprise new and remanufactured modules, clusters and sensors; and hardware products, such as threaded bolts and auto body fasteners, automotive and home electrical wiring components, and other hardware assortments and merchandise.
Featured Stories
- Five stocks we like better than Dorman Products
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Do ETFs Pay Dividends? What You Need to Know
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What is a Secondary Public Offering? What Investors Need to Know
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Dorman Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dorman Products and related companies with MarketBeat.com's FREE daily email newsletter.